levonorgestrel has been researched along with Polycystic Ovarian Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, R; González, JL; Hong, KM; Klar, M; Mandelbaum, RS; Matsuo, K; Obermair, A; Paulson, RJ; Roman, LD; Violette, CJ; Wright, JD | 1 |
| Hu, M; Ji, L; Jin, L; Shao, MJ; Xu, J | 1 |
| Amiri, M; Bidhendi-Yarandi, R; Khalili, D; Nahidi, F; Ramezani Tehrani, F; Tohidi, M | 1 |
| Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
| de Zegher, F; Del Río, L; Díaz, M; Ibáñez, L; López-Bermejo, A; Pozo, ÓJ; Sebastiani, G | 1 |
| Araujo Castro, M; Campos Del Portillo, R; Izquierdo Álvarez, C; Oliván Palacios, B; Prieto Coca, L | 1 |
| Amin, S; Bhat, IA; Fatima, Q; Ganie, MA; Jeelani, H; Kawa, IA; Manzoor, S; Rashid, F; Shah, ZA; Yousuf, SD | 1 |
| Hu, Y; Lin, M; Wang, Y; Xu, X; Zhao, Y | 1 |
| Bian, J; Fang, L; Li, H; Liu, H; Shao, H; Tao, M; Wang, L; Xing, C | 1 |
| Barboza, RP; da Silva, AV; de Melo, AS; de Paula Martins, W; Ferriani, RA; Vieira, CS | 1 |
| Ganie, MA; Mattoo, T; Mudassar, S; Rashid, F; Shekhar, C; Yousuf, SD; Zargar, MA | 1 |
| Du, DF; Li, XL; Zheng, SH | 1 |
| Alanbay, I; Baser, I; Duru, NK; Ercan, CM; Karasahin, KE; Sakinci, M | 1 |
| de Vries, CS; Farmer, RD; Seaman, HE | 1 |
| Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
4 trial(s) available for levonorgestrel and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Female; Humans; Iran; Levonorgestrel; Middle Aged; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Young Adult | 2020 |
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Topics: Adolescent; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Intra-Abdominal Fat; Levonorgestrel; Metformin; Oligomenorrhea; Ovulation; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2017 |
Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Topics: Abortion, Spontaneous; Adult; Biopsy; China; Embryo Implantation; Embryo Transfer; Endometrial Hyperplasia; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prospective Studies; Time Factors; Treatment Outcome | 2015 |
11 other study(ies) available for levonorgestrel and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.
Topics: Adult; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Female; Fertility Preservation; Glucagon-Like Peptide-1 Receptor; Humans; Levonorgestrel; Obesity; Polycystic Ovary Syndrome; Pregnancy; Progestins | 2023 |
Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.
Topics: Carotid Intima-Media Thickness; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 2023 |
Hypercupremia secondary to oral contraceptives: report of 2 cases.
Topics: Ceruloplasmin; Contraceptives, Oral; Copper; Crohn Disease; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Malnutrition; Oligonucleotides; Polycystic Ovary Syndrome; Spectrophotometry, Atomic; Young Adult; Zinc | 2017 |
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
Topics: Adult; Body Mass Index; Coagulation Protein Disorders; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; India; Inflammation; Insulin; Insulin Resistance; Levonorgestrel; Metformin; Polycystic Ovary Syndrome; Risk Factors; Waist-Hip Ratio; Young Adult | 2019 |
Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome.
Topics: Endometrial Hyperplasia; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Polycystic Ovary Syndrome; Treatment Outcome | 2014 |
Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Prospective Studies; Treatment Outcome; Young Adult | 2016 |
Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
Topics: Adolescent; Adult; Chemokine CCL2; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Levonorgestrel; Pilot Projects; Polycystic Ovary Syndrome; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Expression of anti-Müllerian hormone in two rat models of polycystic ovary syndrome.
Topics: Animals; Anti-Mullerian Hormone; Chorionic Gonadotropin; Dehydroepiandrosterone Sulfate; Dimethylpolysiloxanes; Disease Models, Animal; Estrous Cycle; Female; Humans; Levonorgestrel; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Receptors, Peptide; Receptors, Transforming Growth Factor beta | 2016 |
Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Pregnancy; Pregnancy, Multiple; Reproductive Techniques, Assisted | 2010 |
Differences in the use of combined oral contraceptives amongst women with and without acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Polycystic Ovary Syndrome | 2003 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |